Such findings suggest that the variant-associated TREM2 hyperactivation may accelerate AD progression by intensifying microglial receptor activity, which elevates synaptic phagocytosis and contributes to cognitive decline [338]. This evidence concerns the gene TREM2 and Alzheimer disease.